Drug Exposure and Risk of Microscopic Colitis: A Systematic Review and Meta-Analysis

• Published in: Digestive diseases (Basel) Vol. 41; no. 2; p. 217
• Main Authors: Zhang, Shao-Wen, Xu, Ru-Hu, Chen, Dan
• Format: Journal Article
• Language: English
• Published: Switzerland 01.03.2023
• Subjects: Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Aspirin - adverse effects; Colitis; Colitis, Microscopic - chemically induced; Colitis, Microscopic - epidemiology; Diarrhea - chemically induced; Diarrhea - epidemiology; Humans; Pharmacoepidemiology; Collagenous colitis; Lymphocytic colitis; Risk factors
• ISSN: 1421-9875
• DOI: 10.1159/000526809

Microscopic colitis (MC) is a chronic inflammatory bowel disease characterized by watery diarrhoea and a normal radiological and endoscopic appearance. Concern regarding a potential association between drug exposure and MC has recently emerged. We sought to systematically review and summarize the evidence for the potential association. A systematic review and meta-analysis were performed to evaluate the incidence of MC associated with exposure to drug. The PubMed and Embase databases were searched to identify potential studies for inclusion. Twelve case-control studies were included in the meta-analysis. The results showed exposure to NSAID (OR, 1.64; 95% CI: 1.14-2.37; p < 0.001), PPI (OR, 2.36; 95% CI: 1.59-3.52; p < 0.001), SSRI (OR, 2.16; 95% CI: 1.5-3.13; p < 0.001), or aspirin (OR, 2.84; 95% CI: 1.4-5.76; p < 0.001) was related to the incidence of MC; however, such relationships in PPI and SSRI may be modulated by the selection of controls. Furthermore, we did not found a positive association with other drug exposure and MC. This meta-analysis indicated that NSAID, PPI, SSRI, or aspirin consumption may increase the risk for MC. Further studies exploring drug-induced microscopic colitis should include control groups with diarrhoea and not only healthy controls.